Business News • PR NewsWire • Taiho's Lonsurf(R) (trifluridine and tipiracil hydrochloride) Tablets Approved In Japan for Treatment of Advanced Metastatic Colorectal Cancer

Taiho's Lonsurf(R) (trifluridine and tipiracil hydrochloride) Tablets Approved In Japan for Treatment of Advanced Metastatic Colorectal Cancer

Taiho's Lonsurf(R) (trifluridine and tipiracil hydrochloride) Tablets Approved In Japan for Treatment of Advanced Metastatic Colorectal Cancer

TOKYO, March 24, 2014 /PRNewswire/ -- Taiho Pharmaceutical Co., Ltd. (Tokyo, President: Masayuki Kobayashi) announced on March 24 that it has obtained approval in Japan from the Ministry of Health, Labour and Welfare to manufacture and market the oral combination anticancer drug...

View More : http://www.prnewswire.com/news-releases/taihos-lonsurfr-trifluridine-and-tipiracil-hydrochloride-tablets-approved-in-jap...

Releted News by prnewswire

AT&T Invests Nearly $1.3 Billion Over Three Year Period To Enhance Local Networks In Tennessee

Kiadis Pharma Organizes a Satellite Symposium on March 30, 2014 at the 40th Annual Meeting of the European Society for Blood and Marrow Transplantation

Fathom's 2014 Higher-Education Marketing Standard Charts Course for Enrollments

Global Metrology Services Market 2014-2018